CSPC Innovation Pharmaceutical Statistics

Total Valuation

CSPC Innovation Pharmaceutical has a market cap or net worth of CNY 34.26 billion. The enterprise value is 33.90 billion.

Market Cap	34.26B
Enterprise Value	33.90B

Important Dates

The next estimated earnings date is Friday, March 21, 2025.

Earnings Date	Mar 21, 2025
Ex-Dividend Date	n/a

Share Statistics

CSPC Innovation Pharmaceutical has 1.39 billion shares outstanding. The number of shares has decreased by -7.05% in one year.

Current Share Class	n/a
Shares Outstanding	1.39B
Shares Change (YoY)	-7.05%
Shares Change (QoQ)	+9.28%
Owned by Insiders (%)	0.00%
Owned by Institutions (%)	12.08%
Float	331.86M

Valuation Ratios

The trailing PE ratio is 66.75 and the forward PE ratio is 87.65.

PE Ratio	66.75
Forward PE	87.65
PS Ratio	16.76
PB Ratio	8.98
P/TBV Ratio	9.55
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 52.07, with an EV/FCF ratio of -397.39.

EV / Earnings	66.07
EV / Sales	16.59
EV / EBITDA	52.07
EV / EBIT	63.88
EV / FCF	-397.39

Financial Position

The company has a current ratio of 2.69, with a Debt / Equity ratio of 0.00.

Current Ratio	2.69
Quick Ratio	2.14
Debt / Equity	0.00
Debt / EBITDA	0.00
Debt / FCF	-0.01
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is 10.78% and return on invested capital (ROIC) is 6.92%.

Return on Equity (ROE)	10.78%
Return on Assets (ROA)	6.03%
Return on Capital (ROIC)	6.92%
Revenue Per Employee	1.08M
Profits Per Employee	271,929
Employee Count	1,887
Asset Turnover	0.37
Inventory Turnover	4.18

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -19.29% in the last 52 weeks. The beta is -0.21, so CSPC Innovation Pharmaceutical's price volatility has been lower than the market average.

Beta (5Y)	-0.21
52-Week Price Change	-19.29%
50-Day Moving Average	27.49
200-Day Moving Average	28.06
Relative Strength Index (RSI)	32.65
Average Volume (20 Days)	6,288,404

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, CSPC Innovation Pharmaceutical had revenue of CNY 2.04 billion and earned 513.13 million in profits. Earnings per share was 0.37.

Revenue	2.04B
Gross Profit	844.52M
Operating Income	535.33M
Pretax Income	621.03M
Net Income	513.13M
EBITDA	654.85M
EBIT	535.33M
Earnings Per Share (EPS)	0.37

Full Income Statement

Balance Sheet

The company has 1.29 billion in cash and 1.05 million in debt, giving a net cash position of 1.29 billion or 0.93 per share.

Cash & Cash Equivalents	1.29B
Total Debt	1.05M
Net Cash	1.29B
Net Cash Per Share	0.93
Equity (Book Value)	4.75B
Book Value Per Share	2.74
Working Capital	1.48B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -21.34 million and capital expenditures -63.97 million, giving a free cash flow of -85.31 million.

Operating Cash Flow	-21.34M
Capital Expenditures	-63.97M
Free Cash Flow	-85.31M
FCF Per Share	-0.06

Full Cash Flow Statement

Margins

Gross margin is 41.33%, with operating and profit margins of 26.20% and 25.11%.

Gross Margin	41.33%
Operating Margin	26.20%
Pretax Margin	30.39%
Profit Margin	25.11%
EBITDA Margin	32.05%
EBIT Margin	26.20%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 0.27, which amounts to a dividend yield of 1.08%.

Dividend Per Share	0.27
Dividend Yield	1.08%
Dividend Growth (YoY)	156.00%
Years of Dividend Growth	3
Payout Ratio	72.89%
Buyback Yield	7.05%
Shareholder Yield	8.13%
Earnings Yield	1.50%
FCF Yield	-0.25%

Dividend Details

Stock Splits

The last stock split was on April 25, 2024. It was a forward split with a ratio of 1.2.

Last Split Date	Apr 25, 2024
Split Type	Forward
Split Ratio	1.2

Scores

CSPC Innovation Pharmaceutical has an Altman Z-Score of 25.35.

Altman Z-Score	25.35
Piotroski F-Score	n/a